Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_uris is deprecated in /var/www/contraception-esc.com/wp-content/plugins/permalink-manager-pro/permalink-manager.php on line 137

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_permastructs is deprecated in /var/www/contraception-esc.com/wp-content/plugins/permalink-manager-pro/permalink-manager.php on line 138

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_redirects is deprecated in /var/www/contraception-esc.com/wp-content/plugins/permalink-manager-pro/permalink-manager.php on line 139

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_external_redirects is deprecated in /var/www/contraception-esc.com/wp-content/plugins/permalink-manager-pro/permalink-manager.php on line 140

Deprecated: Creation of dynamic property Permalink_Manager_Class::$permalink_manager_alerts is deprecated in /var/www/contraception-esc.com/wp-content/plugins/permalink-manager-pro/permalink-manager.php on line 145
evaluation - contraception-esc.com

evaluation

Evaluation of the 7th ESC Congress

“Changing attitudes to Contraception and Reproductive Health” in

Genova, Italy, April 10 – 13, 2002 given by participants of the congress.

Introduction  Evaluation of the congress speakers

Introduction

 

Evaluation of contributions to

congresses and seminars is seen by the ESC as a tool of quality control.

Evaluation can also contribute to the continuation of high standards of

congresses and seminars and where possible make improvements for the future.

Therefore the ESC asked participants

of the 7th Congress of the European Society for contraception, “Changing

attitudes to Contraception and Reproductive Health”, which was held in

Genova, 10-13th of April 2002, to fill in an evaluation form and score

the sessions attended. A total of 40 contributions were

evaluated, 241 forms were fit for evaluation. The number of hits per

contribution varied from 42 to 198. This means that relative to the total number

of participants the number of evaluation forms is rather low. On the other hand the participants in

general were very satisfied with the quality of the contributions. In a scale

from 1 ‘poor’ to 5 ‘excellent’ the average score was 4,2! The single contribution which scored

highest, was the closing session ‘Future contraception form research to

practice’ which scored an excellent 4,5. Other topics, which scored very high,

were the contributions on sexual transmitted viral infections and the meet the

expert’s session on sexual dysfunction and contraception. All the main session speakers scored

4 or more, but even of the contributions, which scored a little lower, all were

at least satisfactory or higher. The ESC can be very content with this

evaluation. A point of improvement the next time will be to convince the

participants how important it is to fill in these evaluation forms.

 

Evaluation

of the congress speakers

Theme of lecture Session * **
Contraception

and Society

Opening Lecture 4,2 193
Steroid receptors Main Session I From Biology to Contraception 4,1 191
New progestins Main Session I From Biology to Contraception 4,1 198
Implantation Main Session I From Biology to Contraception 4,1 195
Legislation Session 1: Abortion situation in Europe 3,9 109
Statistical information Session 1: Abortion situation in Europe 3,7 109
Changing attitudes towards abortion Session 1: Abortion situation in Europe 3,9 118
Long acting methods Meet the Experts 3 80
Psychological aspects Meet the Experts 3,8 68
The role of the non medical professionals in

contraception

Meet the Experts 3,9 63
OC use and endometriosis Meet the Experts 3,8 42
Contraception in PCO patients Meet the Experts 4 81
Spermicides Meet the Experts 3,5 52
Breast, ovary, endometrium and cervix Session 4: Cancer and contraception 3,5 168
IUD Workshops 4 69
Adolescent forum Workshops 4 90
The Web as a teacher in the contraceptive

field

Workshops 3,3 48
Continuation and compliance of contraceptive

use

Session 6: What do women want? 3,8 113
Counselling in contraception Session 6: What do women want? 4,1 127
Anti-ovulatory effects of progestin

preparations

Main Session II Progestin-only contraception 4,2 181
Clinical profile of progestin contraception Main Session II Progestin-only contraception 4,1 153
Mode of delivery systems (impact on

acceptability)

Main Session II Progestin-only contraception 4 130
Male contraception with androgen plus

progestin

Session 2: Male contraception 4,1 126
Other possibilities Session 2: Male contraception 4 108
Psychological aspects Session 2: Male contraception 3,8 109
Adolescent contraception Meet the Experts 4,2 69
Non-bleeding OC regimens Meet the Experts 4,2 49
Early medical abortions Meet the Experts 3,9 46
Non-viral STD Meet the Experts 3,9 45
Fertility regulation in the perimenopause Meet the Experts 4,2 53
Sexual dysfunction and contraception Meet the Experts 4,3 54
Clinical aspects Session 5: Emergency contraception 4,2 87
Over the counter Session 5: Emergency contraception 4,1 67
Evidence based contraceptive practice Workshops 4 59
Hepatitis Main Session III Sexual transmitted viral

infections

4,1 72
HIV Main Session III Sexual transmitted viral

infections

4,3 78
HPV Main Session III Sexual transmitted viral

infections

4,3 80
Biologic effects Session 3: Oral contraception and CVD 4,1 75
Epidemiologic effects Session 3: Oral contraception and CVD 4 72
Future contraception, from research to

practice

Main Session IV 4,5 47
LEGEND:
*

score on 5 scale: 5 = excellent, 4 = good, 3 = average, 2 = below

average, 1 = poor

**

number of hits = number of persons who evaluated this speaker (total of

participating persons to evaluation: 241)

(back to

news) (back to ESC congress)

home

Scroll to Top